Isolation strategies of regulatory T cells for clinical trials: Phenotype, function, stability, and expansion capacity

Experimental Hematology

Volumn 39, Issue 12, 2011, Pages 1152-1160

  Ukena, Sya N ^a   Höpting, Matthias ^a   Velaga, Sarvari ^a   Ivanyi, Philipp ^a   Grosse, Jens ^a   Baron, Udo ^b   Ganser, Arnold ^a   Franzke, Anke ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b EPIONTIS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CD4+ CD25HI CD127- REGULATORY T LYMPHOCYTE; CD4+ CD25HI CD45RA+ REGULATORY T LYMPHOCYTE; CD4+ CD25HI ICOS+ REGULATORY T LYMPHOCYTE; CD4+ CD25HI REGULATORY T LYMPHOCYTE; CELL EXPANSION; CELL ISOLATION; CELL STABILITY; CELL TRANSFER; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DEMETHYLATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFUSION; LYMPHOCYTE FUNCTION; MALE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ANTIGENS, CD; CELL DIVISION; CELL SEPARATION; CELLS, CULTURED; CLINICAL TRIALS AS TOPIC; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 81155151462     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2011.08.010     Document Type: Article

References (32)

1. Brunstein C.G., Miller J.S., Cao Q., et al. Infusion of ex vivo expanded t regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011, 117:1061-1070.
2. di Ianni M., Falzetti F., Carotti A., et al. Tregs prevent GvHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011, 117:3921-3928.
3. Baecher-Allan C., Brown J.A., Freeman G.J., Hafler D.A. CD4+CD25 (High) regulatory cells in human peripheral blood. J Immunol 2001, 167:1245-1253.
4. Sakaguchi S. Naturally arising Foxp3-expressing CD25(+) CD4(+) regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
5. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells. Nat Immunol 2003, 4:330-336.
6. Miyara M., Yoshioka Y., Kitoh A., et al. Functional delineation and differentiation dynamics of human CD4(+) T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899-911.
7. Ito T., Hanabuchi S., Wang Y.H., et al. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 2008, 28:870-880.
8. Liu W.H., Putnam A.L., Xu-Yu Z., et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4(+) T reg cells. J Exp Med 2006, 203:1701-1711.
9. Seddiki N., Santner-Nanan B., Martinson J., et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006, 203:1693-1700.
10. Seddiki N., Santner-Nanan B., Tangye S.G., et al. Persistence of naive CD45RA(+) regulatory T cells in adult life. Blood 2006, 107:2830-2838.
11. Hoffmann P., Eder R., Boeld T.J., et al. Only the CD45RA(+) subpopulation of CD4(+)CD25(High) T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006, 108:4260-4267.
12. Kleinewietfeld M., Starke M., Di Mitri D., et al. CD49d provides access to "untouched" human Foxp3(+) Treg free of contaminating effector cells. Blood 2009, 113:827-836.
13. Wieczorek G., Asemissen A., Model F., et al. Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 2009, 69:599-608.
14. Floess S., Freyer J., Siewert C., et al. Epigenetic control of the Foxp3 locus in regulatory T cells. PLoS Biol 2007, 5:169-178.
15. Polansky J.K., Kretschmer K., Freyer J., et al. DNA methylation controls Foxp3 gene expression. Eur J Immunol 2008, 38:1654-1663.
16. Baron U., Floess S., Wieczorek G., et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 2007, 37:2378-2389.
17. di Ianni M., Del Papa B., Cecchini D., et al. Immunomagnetic isolation of CD4(+)CD25(+)FoxP3(+) natural T regulatory lymphocytes for clinical applications. Clin Exp Immunol 2009, 156:246-253.
18. Peters J.H., Preijers F.W., Woestenenk R., et al. Clinical grade Treg: GMP isolation, improvement of purity by CD127 depletion, Treg expansion, and Treg cryopreservation. PLoS ONE 2008, 3:e3161.
19. Hoffmann P., Eder R., Kunz-Schughart L.A., Andreesen R., Edinger M. Large-scale in vitro expansion of polyclonal human CD4(+)CD25(high) regulatory T cells. Blood 2004, 104:895-903.
20. Levings M.K., Sangregorio R., Roncarolo M.G. Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001, 193:1295-1301.
21. Carrasco J., Godelaine D., Van Pel A., Boon T., van der Bruggen P. CD45RA on human CD8 T cells is sensitive to the time elapsed since the last antigenic stimulation. Blood 2006, 108:2897-2905.
22. Li Q., Zhai Z., Xu X., et al. Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation. Leuk Res 2010, 34:1158-1168.
23. Hoffmann P., Boeld T.J., Eder R. Loss of FOXP3 expression in natural human CD4(+)CD25(+) regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol 2009, 39:1088-1097.
24. Schmitt A., Tonn T., Busch D.H., et al. Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion 2011, 51:591-599.
25. Solomou E.E., Rezvani K., Mielke S., et al. Deficient CD4(+) CD25(+) FOXP3(+) T regulatory cells in acquired aplastic anemia. Blood 2007, 110:1603-1606.
26. Yu J., Heck S., Patel V., et al. Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood 2008, 112:1325-1328.
27. Aboul-Fotoh L., Abdel Raheem M.M., El Deen M.A., Osman A.M. Role of CD4+CD25+ T cells in children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2011, 33:81-85.
28. Culina S., Mallone R. Pathogenic and regulatory T cells in type 1 diabetes: losing self-control, restoring it, and how to take the temperature. Curr Diab Rep 2011, [Epub ahead of print].
29. McClymont S.A., Putnam A.L., Lee M.R., et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol 2011, 186:3918-3926.
30. Buckner J.H. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nature Rev Immunol 2010, 10:849-859.
31. Leslie M. Regulatory T cells get their chance to shine. Science 2011, 332:1020-1021.
32. Shan J., Guo Y., Luo L., et al. Do CD4(+)Foxp3(+) Treg cells correlate with transplant outcomes: a systematic review on recipients of solid organ transplantation. Cell Immunol 2011, 270:5-12.